Enterprise Value:
$121.21B-$177.19M(-0.15%)Summary
- As of April 2, 2025, VRTX enterprise value is $121.21 billion, with a fall of -$177.19 million (-0.15%) during the most recent trading day.
- Over the past year, VRTX enterprise value has increased by +$21.27 billion (+21.28%).
- VRTX enterprise value is now -6.10% below its all-time high of $129.09 billion.
Performance
VRTX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
VRTX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -0.1% | -0.1% | -0.1% |
| 1 m1 month | +0.5% | +0.5% | +0.5% |
| 3 m3 months | +22.5% | +21.9% | +22.0% |
| 6 m6 months | - | +2.4% | +2.8% |
| ytdytd | +22.5% | +21.9% | +22.0% |
| 1 y1 year | +21.3% | +14.4% | +15.1% |
| 5 y5 years | +119.0% | +112.3% | +114.2% |
VRTX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $129B | -6.1% | $120B | +1.0% |
| 3 m | 3-month | $129B | -6.1% | $98.93B | +22.5% |
| 6 m | 6-month | $129B | -6.1% | $97.88B | +23.8% |
| 1 y | 1-year | $129B | -6.1% | $92.44B | +31.1% |
| 3 y | 3-year | $129B | -6.1% | $53.36B | +127.1% |
| 5 y | 5-year | $129B | -6.1% | $39.95B | +203.4% |
| alltime | all time | $129B | -6.1% | $60.46M | >+9999.0% |
Vertex Pharmaceuticals Incorporated Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $121.21B(+22.5%) |
| 2024 | $98.93B(+53.1%) |
| 2022 | $64.62B(+29.1%) |
| 2021 | $50.06B(-11.2%) |
| 2020 | $56.37B(+3.9%) |
| 2019 | $54.26B(+34.9%) |
| 2018 | $40.22B(+9.0%) |
| 2017 | $36.89B(+105.5%) |
| 2016 | $17.95B(-42.3%) |
| 2015 | $31.10B(+7.5%) |
| 2014 | $28.92B(+67.1%) |
| 2013 | $17.31B(+85.9%) |
| 2012 | $9.31B(+34.3%) |
| 2011 | $6.93B(-6.6%) |
| 2010 | $7.42B(-10.3%) |
| 2009 | $8.28B(+85.1%) |
| 2008 | $4.47B(+62.5%) |
| Date | Value |
|---|---|
| 2007 | $2.75B(-40.6%) |
| 2006 | $4.63B(+49.6%) |
| 2005 | $3.09B(+173.0%) |
| 2004 | $1.13B(+8.7%) |
| 2003 | $1.04B(-27.1%) |
| 2002 | $1.43B(-27.9%) |
| 2001 | $1.98B(-53.6%) |
| 2000 | $4.28B(+389.2%) |
| 1999 | $874.49M(+18.2%) |
| 1998 | $740.03M(-3.8%) |
| 1997 | $769.03M(-6.5%) |
| 1996 | $822.75M(+88.3%) |
| 1995 | $437.02M(+126.9%) |
| 1994 | $192.63M(-4.9%) |
| 1993 | $202.62M(+80.6%) |
| 1992 | $112.20M(-25.4%) |
| 1991 | $150.31M |
FAQ
- What is Vertex Pharmaceuticals Incorporated enterprise value?
- What is the all time high enterprise value for Vertex Pharmaceuticals Incorporated?
- What is VRTX enterprise value year-to-date change?
- What is Vertex Pharmaceuticals Incorporated enterprise value year-on-year change?
What is Vertex Pharmaceuticals Incorporated enterprise value?
The current enterprise value of VRTX is $121.21B
What is the all time high enterprise value for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high enterprise value is $129.09B
What is VRTX enterprise value year-to-date change?
Vertex Pharmaceuticals Incorporated enterprise value has changed by +$22.29B (+22.53%) since the beginning of the year
What is Vertex Pharmaceuticals Incorporated enterprise value year-on-year change?
Over the past year, VRTX enterprise value has changed by +$21.27B (+21.28%)